Target intelligence / Profile preview

Lipopolysaccharide lipid A phosphate group (LPS lipid A phosphate)

Target
LPS lipid A phosphate
Molecular classification
Bacterial cell wall component, Lipid, Anionic molecule
01

Overview

The lipopolysaccharide (LPS) lipid A phosphate groups are critical anionic components located within the outer membrane of Gram-negative bacteria. These phosphate groups, typically found at the 1 and 4' positions of the lipid A disaccharide backbone, serve as essential binding sites for divalent cations such as magnesium and calcium, which cross-link adjacent LPS molecules to maintain membrane structural integrity and provide a robust permeability barrier. Because of their strong negative charge, these phosphate groups are the primary therapeutic target for cationic polypeptide antibiotics, most notably the polymyxin class, including Polymyxin B and Colistin. When these drugs bind to the phosphate groups, they displace the stabilizing cations, causing a detergent-like disruption of the outer membrane that leads to cell lysis. Beyond their structural role, these groups are central to the endotoxic activity of LPS, triggering potent immune responses through the TLR4/MD-2 complex. Bacterial resistance often arises through the enzymatic modification of these phosphate groups, such as the addition of phosphoethanolamine or 4-amino-4-deoxy-L-arabinose, which reduces the overall negative charge and prevents drug binding.

Other names
Lipid A phosphateLPS anionic sitesEndotoxin phosphate groupsLipid A 1-phosphateLipid A 4'-phosphate
02

Mechanism of action

Cationic antimicrobial peptides like polymyxins bind electrostatically to the anionic phosphate groups of lipid A, displacing stabilizing divalent cations (Mg2+ and Ca2+). This displacement disrupts the integrity of the outer membrane, leading to increased permeability, leakage of cytoplasmic contents, and bacterial cell death.

03

Biological functions

Outer membrane stabilizationDivalent cation bindingPermeability barrier maintenanceEndotoxin activity
04

Disease associations

Gram-negative bacterial infectionSepsisEndotoxemiaSeptic shock
05

Safety considerations

NephrotoxicityNeurotoxicityJarisch-Herxheimer-like reaction due to rapid endotoxin releaseEmergence of colistin resistance
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

mcr-1 gene expressionLipid A modification profileSerum endotoxin levelsProcalcitonin

Beyond the preview

Go deeper on Lipopolysaccharide lipid A phosphate group (LPS lipid A phosphate).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide lipid A phosphate group (LPS lipid A phosphate).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call